Fig. 1From: Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo a Chemical structure of moniliformediquinone (MFD). b Effect of MFD on cell viability of HSC-T6 cells. HSC-T6 cells were treated with MFD (0–2.5 μM) for 24 and 48 h. MTT assays were performed to assess cell viability. The data represent mean ± SD of three independent experiments. *P < 0.01 versus the controlBack to article page